Recruiting Advanced Solid Tumors Studies in Morristown
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
TransCon IL-2 β/γ is an investigational drug being developed for treatment of locally advanced or metastatic solid tumors. This is a first-in-human, open-label, Phase 1/2, dose escalation and dose exp...
A Study of ASP1570 Alone or in Combination With Pembrolizumab or Standard Therapies in Adults With Solid Tumors
Immune therapies work with the body's immune system to treat a number of cancers. They work with T-cells, a type of white blood cell, to target and attack specific tumors. However, some tumors can bec...
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
KB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study. The study will evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid ...
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Multicenter, open-label, dose-escalation, safety, tolerability, PK and pharmacodynamic study with a dose expansion at the RP2D to evaluate safety and potential antitumor activity of Q901 as a monother...
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
INDP-D101 is a Phase 1/2, open-label, multi-center, dose escalation and expansion study evaluating the safety, tolerability and clinical activity of Decoy20 as monotherapy and in combination with tisl...
About Advanced Solid Tumors Clinical Trials in Morristown
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 5 advanced solid tumors clinical trials recruiting participants in Morristown, NEW%20JERSEY. These studies are seeking a combined 1,145 participants. Research is being sponsored by Ascendis Pharma Oncology Division A/S, Astellas Pharma Global Development, Inc., Krystal Biotech, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Morristown — FAQ
Are there advanced solid tumors clinical trials in Morristown?
Yes, there are 5 advanced solid tumors clinical trials currently recruiting in Morristown, NEW%20JERSEY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Morristown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Morristown research site will contact you about next steps.
Are clinical trials in Morristown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Morristown studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 5 active trials in Morristown are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov